PO05 | Intensive FVIII replacement in haemophilia patients with hypertrophic synovium: a randomized study
I.L. Calcaterra1, E. Baldacci2, R. Marino3, F. Valeri4, R.C. Santoro5, G. Pasta6, C. Martinoli7, M. Di Minno1 | 1Department of Clinical Medicine and Surgery, Federico II University, Naples; 2Haematology, University Hospital Policlinico Umberto I, Roma; 3Haemophilia Center and thrombosis, Policlinico, Bari; 4Regional Centre for Haemorrhagic and Thrombotic Diseases, AOU Città Della Salute e Della Scienza; Turin; 5Centre for Hemorrhagic and Thrombotic Disorders, Pugliese Ciaccio Hospital, Catanzaro; 6Fondazione IRCCS San Matteo Hospital, Pavia; 7Department of Health Science DISSAL, University of Genoa, Unit of Radiology and IRCCS San Martino Hospital, Genoa, Italy
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Background and Aims: Hypertrophic synovium (HS) is a marker of disease activity in patients with haemophilia (PwH). Although some recommendations suggest intensifying prophylaxis in PwH with HS, no validated schedules are available. We explored the efficacy of intensive Factor VIII (FVIII) replacement treatment in PwH with HS.
Methods: In a randomized, open-label study, PwH with HS were randomized to receive pharmacokinetics-driven prophylaxis targeting a FVIII through level of 8%-12% (intensive treatment arm [ITA]) or 3-5% (standard treatment arm [STA]). The primary outcome was HS reduction/resolution in the two treatment arms.
Results: A total of 39 PwH were randomized to ITA and 36 to STA. During the study, we found a lower Annual Bleeding Rate (ABR) and a higher rate of ABR zero in the ITA than in the STA. HS reduction/resolution was reported by 35.9% of cases in the ITA and by 8.4% in the STA. In detail, in the ITA 10.3% achieved HS reduction and 25.6% complete HS resolution, as compared to 5.6% and 2.8% in the STA. A COX regression showed that ITA was associated to HS reduction/resolution (Hazard ratio [HR]: 4.75, 95% confidence interval [CI]: 1.36-16.57, p=0.014) and to HS complete resolution (HR: 10.79, 95%CI: 1.38-84.45, p=0.023). The analysis on the 127 joints with HS (54 elbows, 41 knees and 32 ankles) consistently confirmed similar results.
Conclusions: In this randomized study, we found a ~5-fold higher rate of HS reduction/resolution and a ~10-fold higher rate of HS resolution in the ITA as compared to the STA.
Altmetrics
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
